Absence of EGFR mutation in the kinase domain in common human cancers besides non-small cell lung cancer
β Scribed by Jong Woo Lee; Young Hwa Soung; Su Young Kim; Won Sang Park; Suk Woo Nam; Jung Young Lee; Nam Jin Yoo; Sug Hyung Lee
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 61 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Mounting evidence has suggested somatic mutations in the __EGFR__ gene are associated with better responsiveness to __EGFR__ tyrosine kinase inhibitors (TKIs) in patients with nonβsmallβcell lung cancer (NSCLC). Some, but not all, studies have reported that the mutations were more frequ
The EGFR family consists of 4 receptor tyrosine kinases, EGFR (ERBB1), ERBB2 (HER2), ERBB3 (HER3) and ERBB4 (HER4). Recent reports revealed that the kinase domains of both EGFR (ERBB1) and ERBB2 gene were somatically mutated in human cancers, raising the possibility that the other ERBB members posse
## Abstract ## Background Deregulation of microRNAs (miRNAs) plays important roles in tumor progression. The aim of this study was to investigate miRβ21 expression in serum of nonβsmall cell lung cancer (NSCLC) and its correlation with prognosis of NSCLC patients. ## Methods Dysregulated miRNAs